Cargando…
Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
To investigate prevalence of anticardiolipin antibodies (aCL) in patients with Behcet's disease (BD) and to determine whether they are related to anti-beta2-glycoprotein I antibodies (aGPI), we measured aCL and aGPI in 47 patients of BD and 14 patients of systemic lupus erythematosus (SLE). The...
Autores principales: | Kang, H. J., Lee, Y. W., Han, S. H., Cho, H. C., Lee, K. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054427/ https://www.ncbi.nlm.nih.gov/pubmed/9741545 |
Ejemplares similares
-
Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
por: Melayah, Sarra, et al.
Publicado: (2022) -
Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19
por: Garcia-Arellano, Gisela, et al.
Publicado: (2023) -
Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes
por: Wu, Li, et al.
Publicado: (2022) -
Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019) -
Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
Publicado: (1994)